Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis II: Collaborative Care
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Esophageal Varices-II: Clinical Features and Management
Myocarditis IV: Nursing Management
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Hanna Blaney1, Adelina Horhat2, Abdulmalik Saleem3
1Medstar Transplant Hepatology Institute, MedStar Georgetown University Hospital, Washington, District of Columbia.
与酒精相关的肝病 (ALD) 和酒精使用障碍 (AUD) 的综合治疗改善了患者的治疗结果. 这种多学科的方法是可行的和有效的管理这些双重条件.
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: